Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check3 days agoChange DetectedAdded a new release tag v3.0.2 and removed the MedlinePlus Genetics topic on Multiple myeloma, along with the older revision note (v3.0.1) and the Back to Top link.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include a new facility name and location, as well as specific medical information regarding plasma cell myeloma and the drug belantamab mafodotin. Additionally, a new version revision has been noted.SummaryDifference0.9%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.